Le Lézard
Classified in: Health, Science and technology
Subjects: PET, ANW

New CUBEX partnership puts innovative technology in the hands of WellHaven veterinarians


PHOENIX, Sept. 11, 2018 /PRNewswire/ -- Pet health, vet health; WellHaven was founded on the principle that you can't have one without the other. A new partnership with CUBEX?the industry leader in inventory management solutions?elevates WellHaven Pet Health hospital operating efficiency, increases practice safety, helps teams succeed, and ultimately, improves quality of life for pets and veterinarians.

At Cubex, we are united in our vision to improve efficiencies for our customers. We are passionate about healthcare and helping those who deliver it by providing sophisticated solutions that allow them to focus their time on patient care. (PRNewsfoto/CUBEX LLC)

Each WellHaven practice will be centered on the CUBEX inventory management system. Replete with front-of-the-pack technology and cloud-based software, CUBEX uses predictive analytics and re-ordering automation to save heaps of time in paperwork and logistics.

"For us, pet health comes first, and we achieve this by putting top technology and resources in the hands of our principal doctors," stated WellHaven Managing Partner, Thomas Reuss. "We're excited to partner with CUBEX?they bring perspective and hard work that makes a difference."

Another valuable benefit is the skyrocketing of safety and compliance as identity verification ensures that the right person withdraws the right dosage at the right time. CUBEX will outfit each practice with DEA-compliant storage and dispensary equipment for managing these controlled substances.

"WellHaven is building sophisticated technology into their foundation, and setting a high industry standard while they're at it," stated CUBEX CEO Anton Visser. "We're proud to kick off this relationship that is sure to strengthen over time." 

About WellHaven Pet Health

WellHaven Pet Health owns and operates veterinary practices that exist to strengthen the positive ripple effect that derives from happy, successful vet hospital owners, clinics that truly address the needs of pet owners, and, by extension, happy, healthy pets. Because when the animals feel the love, everyone feels the difference. Learn more at wellhavenpethealth.com

About CUBEX ®

CUBEX® is a global provider of health care products and services that helps practices measurably reduce the total cost of ownership associated with pharmacy and supplies. The company develops market-leading technologies including CUBEX SupplyBank automated dispensing systems, CUBEX MedFlex and MedBank narcotic management stations, QBud wireless access devices, and the myQLink web-hosted software and business intelligence application. For more information on CUBEX, please visit www.cubex.biz

WellHaven Logo

SOURCE CUBEX LLC


These press releases may also interest you

at 11:45
Vertex Pharmaceuticals today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following...

at 11:15
Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures....

at 11:03
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...



News published on and distributed by: